Synmosa Biopharma Corporation reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 966.67 million compared to TWD 760.34 million a year ago. Net income was TWD 125.13 million compared to TWD 60.96 million a year ago. Basic earnings per share from continuing operations was TWD 0.3814 compared to TWD 0.1816 a year ago. Diluted earnings per share from continuing operations was TWD 0.3814 compared to TWD 0.1816 a year ago.